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ABSTRACT 
The present study is prospective and observational non-interventional study was conducted in tertiary care center. All suspected 
ADRs which are observed in hospital stay will be assessed for causality, severity, preventability and predictability. The results were 
presented as number and percentage. Among the 7697 cases ( both males and females), a total of 240 ADRs were detected, an 
overall incidence of 03.11 % adverse drug reactions in inpatients. The high prevalence of ADR mostly observed in the age group 
between 1-10 years 48 (20.00%)  From this 240 ADR’s where 7.96% on continuing t, 38.36% are recovering, 47.08% are recovered. 
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INTRODUCTION  
The WHO defines an “Adverse drug reactions “any 
response to a drug which is noxious and   unintended 
and which occurs or doses normally used in man of 
prophylaxis diagnosis or therapy of disease or for the 
modification of physiologic function”.1 
Pharmacovigilance has been defined by the WHO as 
‘the science and activities relating to the “detection, 
assessment, understanding and prevention of adverse 
effects or any other drug-related problems”.2 
Adverse drug reactions (ADRs) are types of adverse 
drug events (ADEs). ADEs include ADRs, medication 
errors and other drug-related problems. ADEs are the 
negative consequences of drug misadventures. Henri 
Manasse defined drug misadventure as the iatrogenic 
hazard that is an inherent risk when drug therapy is 
indicated.  
The American Society of Health- System Pharmacists 
(ASHP) defines significant ADRs as any unexpected, 
unintended, undesired, or excessive response to a drug 
that includes the following.
3,4,5 
 Requires discontinuing the drug 
 Requires changing the drug therapy 
 Requires modifying the dose 
 Necessitates admission to the hospital 
 Prolongs stay in a health care facility 
 Necessitates supportive treatment 
 Significantly complicates diagnosis 
 Negatively affects prognosis or results in temporary 
or permanent harm, disability or death. 
METHODOLOGY 
Study Location 
The study is carried out at Aware Global Hospital in 
General Medicine & all Clinical Departments. 
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Study Design 
Prospective, Observational and Non- interventional. 
Study Period 
Study period for data collection was carried out for 
3years (March 2015 To March 2018 ) 
Study Setting                
Study includes only those patients who experience an 
adverse reaction to medicine used either during their 
stay in hospital (IPD) or visiting the outpatient 
departments (OPD). 
Patients Selection: 
Study participants were inpatients in general medicine 
department according to the inclusion and exclusion 
criteria. 
 Inclusion Criteria 
 All patients admitted in Aware Global Hospitals. 
 All suspected ADRs that conforms to WHO’s 
definition. 
 Patients of either sex receiving treatment. 
 Any patient who developed ADR during the 
treatment period.  
 Patients willing to Participate. 
 
Exclusion Criteria 
 Out Patient Dept. (OPD) patients. 
 Day care surgery patients.  
 Patients unable to respond to verbal questions.  
 Patients who are not willing to participate. 
 Emergency Patients. 
 
ANALYSIS OF ADRs 
Types of adverse drug reactions based on Rawlins 
and Thompson classification:  
In this classification, the ADRs are categorized into two 
classes viz type A and type B reactions. 
Causality Assessment:
7
 
Different scales for assessing causality relationship 
between suspected drug and reaction was established by 
using World Health Organization (WHO) Causality 
Assessment Scale . 
Severity Assessment:  
The severity of reported reactions was assessed by using 
Hartwig & Seigel scale which are categorized into mild, 
moderate and severe  
Preventability Assessment:  
The preventability of reported ADRs was assessed by 
using Modified Shumock and Thornton scale and was 
categorized as definitely preventable, probably 
preventable and not preventable, 
Predictability Assessment:  
Criteria for determining predictability of ADRs. 
RESUTLS 
During the study period of total of 7697 patients were 
screened in the hospital. Out of which 240 patients 
encountered ADR’s. 
Among 240 cases the higher prevalence of adverse drug 
reactions was observed in patients having past medical 
history of CVS diseases 57(23.75%) followed by CNS 
disease 50(20.84%), Skin disease 32(13.34%), 
Metabolic disease 28(11.66%), Renal disease 
19(07.92%), Immune disease 16(06.67%), GI disease 
10(04.16%), Respiratory disease 05(02.08%) and Others 
23(09.58%).
 
 
Figure 1: Distribution according to Past Medical History 
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2 ) ADRs were distributed according to the WHO 
ART system codes 
It includes different systems and   number of ADR’S 
found in each system:  most of ADRs were experienced  
by  Gastrointestinal  72 (25.71%) reactions followed by 
Dermatology 31 (21.78%) reactions, Central  nervous  
32 (11.42%) reactions, Endocrine  27 (09.64%) 
reactions,  Hepatic system  and 
Haematology17(06.07%) reactions,  Cardiovascular 12 
(04.28%), Otic system 10(03.57), Renal System 09 
(03.21%), Muscular skeletal 7(02.50%) ,Ophthalmic  
03(01.07%) and General disorders-13(04.64%). 
 
 
Figure 2: ADRs were distributed according to the WHO ART system codes 
 
 3) Causality assessment adverse drug reactions according WHO probability scale.  
Sl.no WHO probability scale No.of ADRs Percentage 
1 Certain 06 2.5 % 
2 Probable 88 36.66 % 
3 Possible 113 47.08 % 
4 Unassessable / Unclassifiable 22 9.16 % 
5 Unlikely 07 2.91 % 
6 Conditional/Unclassified 04 1.66 % 
 Total 240 100 % 
 
 
Figure 3: Causality assessment adverse drug reactions according WHO probability scale. 
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4 ) Assessment of severity of adverse drug reactions 
according Modified Hartwig and Siegel scales  
The 240 ADRs severity was assessed, most of the 
patients are at level-4A 94 (39.16%) followed by lavel-
4B 79 (32.91%), at level-5 17 (07.03%) of patients, 25 
(10.41%) patients at level-3 and 06 patients severity at 
mild 7 (02.91%) and 6 (2.5%) patients are at level-1 and 
level-2 respectively.  2 (00.71%) patients have 
permanent harm at level-6. 
   
 
Figure 4: Assessment of severity of adverse drug reactions according Modified Hartwig and Siegel scales. 
5 ) Assessment adverse drug reactions Predictability 
S. No Preventability No. of ADRs Percentage 
1 Definitely Preventable 142 59.16 % 
2 Probably Preventable 87 36.25 % 
3 Not Preventable 11 4.58 % 
* Total 240 100 % 
 
 
Figure 5: Assessment adverse drug reactions 
Preventability 
CONCLUSION 
Among age groups adults were predominant over 
children andgeriatric in terms of prevalence, while males 
have higher risk to develop ADRs among children and 
adults and in geriatrics both the genders have high risk 
in developing ADRs. Among the 240 cases documented 
60.83% were male and 39.17% were female, showing 
1.55 times higher risk for males to develop ADRs and 
shown 1.105 times higher risk for ADRs in individuals 
of urban area compared to rural area. Among all the 
individuals regardless of sex the distribution of ADRs is 
significant over rural areas. Among 240 cases the higher 
prevalence of adverse drug reaction was observed in 
patients having past medical history of CVS diseases 
and CNS disease. And most of ADRs were experienced 
by Gastrointestinal and Dermatology. The risk factors 
which are highly involved among ADRs are Self-
medication with non-prescribed medications followed by 
Inappropriate Lack of knowledge (About ADRs)Poly 
Pharmacy or Multiple Drug Therapy Wrong time and 
administration, Age, Hypersensitivity and drug with 
narrow therapeutic index. Most of ADRs were identified 
by Doctors or Prescribers.  
ADR reporting and monitoring in a multi super specialty 
tertiary care hospital must be continuous and ongoing 
process and it should be record for both old and newly 
marketed drugs and medicinal products. This will 
provide baseline data regarding the safety and efficacy 
of various drugs which are continuously and rarely used 
drugs.  
Serious ADRs responsible for prolonged hospitalization 
enhance morbidity and also cause economic burden on 
patient and hospital. So ADR monitoring is considered 
very important task in hospital, as it justifies the benefit 
versus risk ratio of drugs to direct patient.  
 Hence, it can be concluded from the present study that 
high level implementation of ADR monitoring and 
reporting should be done so as to provide optimum and  
safe patient care for obtain required therapeutic 
outcome.
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